Results 191 to 200 of about 54,262 (254)

Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]

Arterioscler Thromb Vasc Biol
Hisada Y, Mackman N.
europepmc   +1 more source

FabG moonlights as an extracellular adhesin mediates cytoadhesion of Streptococcus suis via interaction with plasminogen. [PDF]

BMC Microbiol
Guo G, Zhou Y, Li P, Li Q, Yu Y, Zhang W.   +5 more
europepmc   +1 more source

Global research trends and therapeutic potential of fibrinolytic enzymes. [PDF]

J Genet Eng Biotechnol
Hazare C, Bhagwat P, Singh S, Pillai S.
europepmc   +1 more source

Myocardial Infarction in a Patient With Homozygous Plasminogen Activator Inhibitor-1 (PAI-1) 4G/4G Mutation: A Case Report. [PDF]

Cureus
Manasrah A, Khan F, Yarkoni A, Kashou H, Rehman A.   +4 more
europepmc   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Bioprinted Micro-Clots for Kinetic Analysis of Endothelial Cell-Mediated Fibrinolysis. [PDF]

Adv Healthc Mater
Chang JJ, Brew K, Hamilton JAG, Kumar V, Diaz JA, Takayama S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tissue Plasminogen Activator

New England Journal of Medicine, 1988
TISSUE plasminogen activator (t-PA) is a naturally occurring protein that catalyzes the conversion of the inactive proenzyme plasminogen into the active serine protease plasmin.
John A. Oates, Alastair J.J. Wood, Joseph Loscalzo, Eugene Braunwald   +3 more
openaire   +2 more sources

Mechanisms of Plasminogen Activation by Mammalian Plasminogen Activators

Enzyme, 1988
Plasminogen activators convert the proenzyme plasminogen to the active serine protease plasmin by hydrolysis of the Arg560-Val561 peptide bond. Physiological plasminogen activation is however regulated by several additional molecular interactions resulting in fibrin-specific clot lysis.
H R, Lijnen, D, Collen
openaire   +2 more sources

Plasminogen activator inhibitors

Trends in Cardiovascular Medicine, 1991
Plasminogen activator inhibitors (PAIs) regulate plasminogen activation in normal and pathologic processes. Plasminogen activator inhibitor 1 (PAI-1) is the major physiologic inhibitor of both tissue-type and urokinase-type plasminogen activators. It is a highly regulated single-chain glycoprotein, whose overexpression in vivo impairs the fibrinolytic ...
J, Schneiderman, D J, Loskutoff
openaire   +2 more sources

Glycated Proteins Modulate Tissue–Plasminogen Activator-Catalyzed Plasminogen Activation

Biochemical and Biophysical Research Communications, 1997
Plasminogen activation by tissue-plasminogen activator (t-PA) is accelerated by the presence of a macromolecular surface, which acts as a template that brings enzyme and substrate in close proximity. Modification of lysine residues, which are important for this template function, occurs in diabetic patients as a consequence of glycation of proteins. In
I W, Bobbink, W L, Tekelenburg, J J, Sixma, H C, de Boer, J D, Banga, P G, de Groot   +5 more
openaire   +2 more sources